Sign In
News Digest /
Income Statements
Income Statements
12:01pm, Tuesday, May 13, 2025
Transuite.Org Inc. Advances AI Innovations Amid Financial Restructuring and Notable Quarterly Losses
Company Overview: Transuite.Org Inc. (PINK: TRSO) is an online translation service provider based in Nevada. The company is focusing on establishing a more innovative platform, including AI-driven services for translation and other applications, while also navigating financial restructuring and e...
12:01pm, Tuesday, May 13, 2025
Company Overview: Juniata Valley Financial Corp. (OTCMKTS: JUVF) is a Pennsylvania-based bank holding company operating primarily through its wholly owned subsidiary, The Juniata Valley Bank. The Company’s primary income sources are from banking operations including interest from various loans an...
12:00pm, Tuesday, May 13, 2025
Golden Growers Cooperative (OTCMKTS: GGROU)
Current Events: Golden Growers Cooperative is undergoing significant changes as it prepares for the sale of its 50% interest in ProGold LLC to Cargill following the expiration of their facility lease on December 31, 2026. Members of the Cooperative have...
11:01am, Tuesday, May 13, 2025
Peoples Financial Corporation (NASDAQ: PFBX) has released its quarterly financial results for Q1 2025, ending March 31, 2025. The financial report illustrates a mix of challenges and improvements, as the company continues to navigate an evolving economic landscape.
Key Financial Highlights:
Net ...
11:01am, Tuesday, May 13, 2025
Company Overview: Table Trac, Inc. (PINK: TBTC) specializes in developing information and management systems for casino operations, providing software solutions that enhance operational efficiency and analytics for gaming establishments.
Key Financial Results (Q1 2025 vs Q1 2024):
Revenues: Incr...
11:00am, Tuesday, May 13, 2025
Trio-Tech International (NYSE: TRT) has reported its financial results for the third quarter of Fiscal 2025, revealing significant shifts in revenue and profitability amid challenging market conditions. The company has made strategic changes in its business model, adjusting its focus from a heavy...
10:03am, Tuesday, May 13, 2025
Loar Holdings Inc. (NYSE: LOAR)
Loar Holdings Inc. has reported a strong performance for the first quarter ended March 31, 2025. The company continues to thrive in the aerospace and defense sector, showcasing significant growth in net sales and net income. However, it faces challenges in cost man...
10:03am, Tuesday, May 13, 2025
Lifeway Foods, Inc. (NASDAQ: LWAY) has released its quarterly financial results for the three months ended March 31, 2025. Below are the key points and statistics extracted from the income statement, highlighting both the positive and negative aspects of the company's financial performance during...
10:02am, Tuesday, May 13, 2025
Optex Systems Holdings, Inc. (OTCBB: OPXS) reported its financial results for the quarter ended March 30, 2025, showcasing significant growth driven by increased demand and production capabilities.
Key Financial Highlights:
**Revenue** for Q2 2025 rose to **$10,730 million**, marking a **25.9%**...
10:02am, Tuesday, May 13, 2025
United-Guardian, Inc. (NASDAQ: UG) has released its quarterly report for Q1 2025, showing notable shifts in its financial performance.
Key Financial Highlights:
Net Sales: $2,481,127, down 24% from Q1 2024 ($3,254,944)
Cost of Sales: $1,123,076, a reduction from $1,556,490, resulting in a margin...
10:01am, Tuesday, May 13, 2025
Silicon Laboratories Inc. (NASDAQ: SLAB) Q1 2025 Financial Summary
Silicon Laboratories has released its financial results for the quarter ending April 5, 2025. The company reported significant changes both positively and negatively across various financial metrics in its income statement.
Key Hi...
10:01am, Tuesday, May 13, 2025
Company Overview: John Marshall Bancorp, Inc. (NASDAQ: JMSB) is a bank holding company based in Reston, Virginia, primarily serving the Washington D.C. metropolitan area. The Company operates through its wholly-owned subsidiary, John Marshall Bank, and is engaged in the provision of various banki...
10:01am, Tuesday, May 13, 2025
SunLink Health Systems, Inc. (NYSE: SSY) has released its latest financial results through a quarterly report ending March 31, 2025. The performance reflects ongoing challenges, primarily linked to the aftermath of the COVID-19 pandemic, as well as strategic shifts within the company.
Key Financi...
10:00am, Tuesday, May 13, 2025
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) is a clinical-stage biotechnology company focusing on innovative biologic medicines, particularly in oncology. The company has advanced its lead product candidates, namely SON-1010, SON-080, and SON-1210, through various clinical trials and col...
09:07am, Tuesday, May 13, 2025
NetBrands Corp. (PINK: GDMK) has released its quarterly report for the three months ended March 31, 2025. This period has been critical for the company as it navigates significant challenges and strives for recovery.
Key Financial Highlights:
Net Sales: $0 (unchanged from Q1 2024).
Net Loss: $10...
09:07am, Tuesday, May 13, 2025
Monopar Therapeutics Inc. (NASDAQ: MNPR) has recently released its financial results for the first quarter ended March 31, 2025. Below is an overview of the company's financial performance and key points from the income statement.
Financial Highlights
Net Loss: The company's net loss was $2.625 ...
09:07am, Tuesday, May 13, 2025
NeuroOne Medical Technologies Corporation (OTCBB: NMTC) is focused on developing and commercializing thin film electrode technology for a variety of neurological applications. The company announced its quarterly results for the period ending March 31, 2025, revealing both positive performance met...
09:06am, Tuesday, May 13, 2025
Ovid Therapeutics Inc. (NASDAQ: OVID) is currently navigating through a complex financial situation as it focuses on the development of pharmacological solutions for brain conditions. Here’s a breakdown of the essential details surrounding their latest financial performance and key developments.
...
09:06am, Tuesday, May 13, 2025
MeiraGTx Holdings plc (NASDAQ: MGTX) is a clinical-stage gene therapy company facing continued financial challenges as indicated in its recent quarterly report for Q1 2025.
Key Points from the Q1 2025 Income Statement:
Service revenue increased to $1.926 million from $0.697 million in Q1 2024, r...
09:05am, Tuesday, May 13, 2025
BioForce Nanosciences Reports Financial Struggles Amid Cash Increase and No Sales Revenue in Q1 2025
BioForce Nanosciences Holdings, Inc. (PINK: BFNH) has released its quarterly report for the period ending March 31, 2025, detailing significant financial challenges while navigating the supplement market.
Positive Aspects:
Increase in Assets: Cash increased from $862 at the end of December 2024 ...
09:05am, Tuesday, May 13, 2025
Coya Therapeutics, Inc. (NASDAQ: COYA) reported its quarterly financial results for the period ending March 31, 2025. The company is focused on developing proprietary therapies targeting regulatory T cells to address various diseases.
Key Highlights from the Income Statement:
Collaboration reven...
09:05am, Tuesday, May 13, 2025
Atossa Therapeutics, Inc. (NASDAQ: ATOS) has released its quarterly report for the period ending March 31, 2025. The report highlights continued losses while providing insights into revenue challenges and operational strategies.
Key Financial Highlights:
Net Loss: $6.7 million for Q1 2025, up fr...
09:04am, Tuesday, May 13, 2025
Verb Technology Company, Inc. (NASDAQ: VERB) has released its financial results for the first quarter of 2025, showcasing significant growth in revenue while still facing challenges in overall profitability.
Key Financial Highlights:
Revenue: $1,305,000 for Q1 2025, up from $7,000 in Q1 2024, re...
09:04am, Tuesday, May 13, 2025
Artelo Biosciences, Inc. (NASDAQ: ARTL) has recently reported financial results for the first quarter ended March 31, 2025. The company continues to focus on developing therapeutics that modulate lipid-signaling pathways, particularly through its key product candidates ART27.13 and ART26.12.
Key ...
09:04am, Tuesday, May 13, 2025
Company Overview:
CG Oncology, Inc. (NASDAQ: CGON) is a late-stage clinical biopharmaceutical company focused on developing its product candidate, cretostimogene grenadenorepvec, for bladder cancer treatment. The company is at a clinical stage and has not yet projected significant revenues withou...
09:03am, Tuesday, May 13, 2025
Company Overview
Lionheart Holdings, Inc. (NYSE: CUB) is a blank check company formed to facilitate a business combination. Incorporated in the Cayman Islands on February 21, 2024, the company has not commenced any operations yet as it aims to identify a target for a business combination. Recent ...
09:03am, Tuesday, May 13, 2025
Candel Therapeutics, Inc. (NASDAQ: CADL) is a clinical-stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies for cancer treatment. As of March 31, 2025, the company reported progress in its clinical trials, ongoing strategic partnerships, and faced various fina...
09:02am, Tuesday, May 13, 2025
Hydrofarm Holdings Group, Inc. (NASDAQ: HYFM) has reported its financial results for the first quarter of 2025, amidst challenging market conditions.
Recent developments indicate a consolidation within the company as it continues to navigate adverse market conditions, primarily stemming from a...
09:02am, Tuesday, May 13, 2025
Intelligent Bio Solutions Inc. (NASDAQ: GBS)
Company Overview:
Intelligent Bio Solutions Inc. (INBS) is focused on developing rapid, non-invasive medical testing technologies. They operate mainly through their products such as the Intelligent Fingerprinting Drug Screening System.
Income Statement...
09:02am, Tuesday, May 13, 2025
Company Overview:
Oblong, Inc. (NYSE: OBLG) operates in the technology sector, providing multi-stream collaboration technologies and managed services for video collaboration and network applications.
Financial Overview:
For the quarter ending March 31, 2025, Oblong reported a total revenue of $62...
09:01am, Tuesday, May 13, 2025
Company Overview
QT Imaging Holdings, Inc. (NASDAQ: QTI) is a medical device company focused on developing innovative body imaging systems using low-frequency sound waves. The company aims to improve health outcomes through its QT Breast Scanner, which has received FDA clearance.
Recent Developme...
09:01am, Tuesday, May 13, 2025
Quince Therapeutics, Inc. (NASDAQ: QNCX) reported its financial results for the first quarter of 2025, revealing a significant increase in losses and operational expenses as the company navigates its clinical development.
Key Financial Highlights:
Cash Position: Cash and cash equivalents reached...
09:01am, Tuesday, May 13, 2025
Giftify, Inc. (PINK: RSTN) has reported its quarterly financial results for the period ending March 31, 2025. Here's a summary of key developments along with analysis of its income statement.
Key Highlights:
Net Sales: Increased to $22.28 million from $21.52 million year-over-year, driven largel...
09:00am, Tuesday, May 13, 2025
Company Overview: 908 Devices Inc. (NASDAQ: MASS) specializes in handheld and desktop devices aimed at chemical analysis in various applications, such as health and safety. The company has undergone significant changes recently, including the sale of its Desktop Portfolio to Repligen Corporation...
08:04am, Tuesday, May 13, 2025
Minerva Neurosciences, Inc. (NASDAQ: NERV) Overview
As of March 31, 2025, Minerva Neurosciences, Inc. continues to operate as a clinical-stage biopharmaceutical company, focusing on developing proprietary product candidates aimed at treating central nervous system diseases. Despite recent regulat...
08:04am, Tuesday, May 13, 2025
Cellectar Biosciences, Inc. (NASDAQ: CLRB) has recently released its quarterly earnings report for the period ending March 31, 2025. The company is focused on the research and development of cancer therapies utilizing its proprietary Phospholipid Drug Conjugate (PDC) platform.
Key Financial Highl...
08:04am, Tuesday, May 13, 2025
Instil Bio, Inc. (NASDAQ: TIL) Overview
Instil Bio is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for cancer treatment. The company's current portfolio is highlighted by its lead product candidate, AXN-2510/IMM2510, a bispecific antibody targeting programm...
08:03am, Tuesday, May 13, 2025
Company Overview: Passage Bio, Inc. (NASDAQ: PASG) is a clinical-stage genetic medicines company focused on developing therapies for neurodegenerative diseases.
Recent Developments:
As of March 31, 2025, the company reported an accumulated deficit of $674.6 million.
Cash and cash equivalents amo...
08:03am, Tuesday, May 13, 2025
Landsea Homes Corporation (NASDAQ: LSEAW) recently released its financial results for the first quarter of 2025, revealing both strengths and challenges within its performance metrics.
Key Financial Highlights:
Total Revenue: Increased to $310.8 million from $294.0 million year-over-year.
Home S...
08:03am, Tuesday, May 13, 2025
BK Technologies Corporation (NYSEARCA: BKTI)
Recent Updates:
Q1 2025 saw an increase in net sales to $19.05 million, a 4.5% rise from $18.23 million in Q1 2024.
Gross profit margin improved notably to 47.0% from 34.5%; attributed to better product mix and material cost reductions.
Operating inco...
